Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues OSRH Q4 2025 Earnings EPS Misses Estimates as Company Faces Operational Headwinds ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline EPM Q1 2026 Earnings Deep EPS Miss Punishes Stock as Revenue Details Remain Unreported OWLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Despite Stock Decline Firefly Neuroscience AIFF Q3 1998 Earnings Heavy Loss Surprises Analysts Yet Stock Rises THR Q1 2026 Earnings Narrow EPS Miss Weighs on Shares JBGS Q1 2026 Earnings Positive EPS Marks a Step Forward Amidst Market Uncertainty ORGN Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Business Restructuring AFYA Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain